SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

DiaMedica Therapeutics Inc. (DMAC)
Score window: May. 30, 2025 to May. 29, 2026

Back View Correspondence
Probe Score
2.5 / 10
Letters
2
Latest Activity
Aug. 20, 2025
Version
v1

Score Breakdown

Letter Count
2.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Aug. 20, 2025 CORRESP Neutral/Informational Moderate DiaMedica Therapeutics Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-3, originally filed on August 1… Read Filing EDGAR
Aug. 18, 2025 UPLOAD Neutral/Informational Low The SEC correspondence dated August 18, 2025, informs DiaMedica Therapeutics Inc. that their registration statement on Form S-3, filed on August 12, 2025, has not been reviewed an… Read Filing EDGAR
Aug. 6, 2025 CORRESP Neutral/Informational Moderate DiaMedica Therapeutics Inc. has submitted a request for the acceleration of the effective date of its registration statement on Form S-3, filed on August 1, 2025. The company seek… Read Filing EDGAR
Aug. 5, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to DiaMedica Therapeutics Inc. that they will not review the company's registration statement filed on August 1, 2025. The letter emphasizes the company's… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.